| Literature DB >> 30189061 |
Andrew P Cap1, Andrew Beckett1, Avi Benov1, Matthew Borgman1, Jacob Chen1, Jason B Corley1, Heidi Doughty1, Andrew Fisher1, Elon Glassberg1, Richard Gonzales1, Shawn F Kane1, Wilbur W Malloy1, Shawn Nessen1, Jeremy G Perkins1, Nicolas Prat1, Jose Quesada1, Michael Reade1, Anne Sailliol1, Philip C Spinella1, Zsolt Stockinger1, Geir Strandenes1, Audra Taylor1, Mark Yazer1, Barbara Bryant1, Jennifer Gurney1.
Abstract
Whole blood is the preferred product for resuscitation of severe traumatic hemorrhage. It contains all the elements of blood that are necessary for oxygen delivery and hemostasis, in nearly physiologic ratios and concentrations. Group O whole blood that contains low titers of anti-A and anti-B antibodies (low titer group O whole blood) can be safely transfused as a universal blood product to patients of unknown blood group, facilitating rapid treatment of exsanguinating patients. Whole blood can be stored under refrigeration for up to 35 days, during which it retains acceptable hemostatic function, though supplementation with specific blood components, coagulation factors or other adjuncts may be necessary in some patients. Fresh whole blood can be collected from pre-screened donors in a walking blood bank to provide effective resuscitation when fully tested stored whole blood or blood components are unavailable and the need for transfusion is urgent. Available clinical data suggest that whole blood is at least equivalent if not superior to component therapy in the resuscitation of life-threatening hemorrhage. Low titer group O whole blood can be considered the standard of care in resuscitation of major hemorrhage.Entities:
Mesh:
Year: 2018 PMID: 30189061 DOI: 10.1093/milmed/usy120
Source DB: PubMed Journal: Mil Med ISSN: 0026-4075 Impact factor: 1.437